Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BECTON DICKINSON & CO Director's Dealing 2025

Jan 21, 2025

30003_dirs_2025-01-21_c8a53067-9d5e-4e6a-a233-9a0deb8c25f5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BECTON DICKINSON & CO (BDX)
CIK: 0000010795
Period of Report: 2025-01-17

Reporting Person: Garrison Michael David (EVP & President, Medical)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-01-17 Common Stock S 597 $236.51 Disposed 5544 Direct